drugset / Trial / NCT02097394

The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

NCT02097394 ↗

Phase 4 Unknown 200 enrolled RenJi Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

The study hypothesis is whether digestion enzyme(Combizym) and intestinal flora drugs(Bifidobacteria) can decease recurrence rate of colon polyps

Timeline

Start
2013-06
Primary completion
2020-06
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bifidobacteri Other / unclassified 2 unknown Oral
Comparator Combizym Unknown 1 unknown Oral